Halozyme Therapeutics competitorsClear all

Partner Therapeutics's top competitors include Verastem Oncology and Blueprint Medicines.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Partner Therapeutics
Partner Therapeutics
Partner Therapeutics is developing and commercializing cancer medicines and combination therapies.
Verastem Oncology
Verastem Oncology
Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer.
Blueprint Medicines
Blueprint Medicines
Blueprint Medicines discovers and develops highly selective kinase inhibitors for patients with genomically defined cancers.
Founding Date
Founding Date
2017
Founding Date
2010
Founding Date
2011
Type
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Lexington, US HQ
Boston, US
Lynnwood, US
Locations
Needham, US HQ
Walsrode, DE
Locations
Cambridge, US HQ
Amsterdam, NL
Lugano, CH
Zug, CH
Cambridge, US
Employees
Employees
1791% increase
Employees
4864% decrease
Employees
38376% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
196.8 m
Valuation ($)
3.3 b
Twitter followers
Twitter followers
144
Twitter followers
2.5 k
Twitter followers
2.6 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
5
Number of tweets (last 30 days)
14
Number of tweets (last 30 days)
15
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
3.8
Average likes per tweet (last 30 days)
8.2
Average likes per tweet (last 30 days)
3.9
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
86.67%
Alexa Website Rank
Alexa Website Rank
120997
Alexa Website Rank
N/A
Alexa Website Rank
182678
Employee Rating
Employee Rating
4.4
Employee Rating
4.3
Employee Rating
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$88.5m (FY, 2020)
Revenue (est.)
$793.7m (FY, 2020)
Cost of goods
Cost of goods
N/A
Cost of goods
$33.7m (FY, 2020)
Cost of goods
$425k (FY, 2020)
Gross profit
Gross profit
N/A
Gross profit
$54.8m (FY, 2020)
Gross profit
$793.3m (FY, 2020)
Net income
Net income
N/A
Net income
($67.7m) (FY, 2020)
Net income
$313.9m (FY, 2020)

Funding

Total funding raised
Total funding raised
$ 60m
Total funding raised
$ 170m
Total funding raised
$ 115m
For sources of this data, please see the company profile

View company profiles

Verastem Oncology
HQ
Needham, US
Employees
48

Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer.

View company
Blueprint Medicines
HQ
Cambridge, US
Employees
383

Blueprint Medicines discovers and develops highly selective kinase inhibitors for patients with genomically defined cancers.

View company